IP Library Granted Patent US 11,850,310
Granted Patent B2
US 11,850,310 · App. 17/195,925 · Granted Dec 26, 2023

Staple cartridge including an adjunct

Inventors: Frederick E. Shelton, IV (Hillsboro, OH); Jeffrey S. Swayze (West Chester, OH)
Assignee: Cilag GmbH International
A61K9/70A61B17/07292A61B2017/00004A61B2017/00526A61B2017/00884A61B2017/00893
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,850,310
App. No.
17/195,925
Filed
Mar 9, 2021
Granted
Dec 26, 2023
Kind
B2
Art Unit
3731
USPC
424/400
Abstract

A tissue thickness compensator may generally comprise a compressible core comprising a plurality of movable particles, and a wrap surrounding the compressible core. The plurality of movable particles may comprise at least one medicament. A tissue thickness compensator may generally comprise a compressible core comprising a plurality of crushable particles, and a wrap surrounding the compressible core. The plurality of crushable particles may comprise at least one medicament. The compressible core may comprise a material selected from a group consisting of a biocompatible material. The wrap may comprise a material selected from a group consisting of a biocompatible material. Articles of manufacture comprising the tissue thickness compensator and methods of making and using the tissue thickness compensator are also described.

Claims (34)

1. A staple cartridge, comprising:

a cartridge deck;

a longitudinal slot extending through said cartridge deck from a proximal end to a distal end;

staple cavities defined in said cartridge deck;

staples removably stored in said staple cavities; and

an adjunct positioned on said cartridge deck, said adjunct comprising:

an outer layer comprising a haemostatic agent, wherein the outer layer defines a cavity; and

an inner layer, wherein said inner layer comprises a biocompatible material, wherein said inner layer is positioned within the cavity, and wherein said adjunct is configured to be compressed during a firing motion.

2. The staple cartridge of claim 1 , wherein said outer layer further comprises an anti-adhesion agent.

3. The staple cartridge of claim 1 , wherein said inner layer comprises fibers.

4. The staple cartridge of claim 1 , wherein said inner layer comprises a powder medicament.

5. The staple cartridge of claim 1 , wherein said outer layer is configured to maintain a liquid barrier between an environment outside of said outer layer and said cavity in a compressed state.

6. The staple cartridge of claim 5 , wherein said outer layer is configured to maintain said liquid barrier until being breached by at least one of said staples during a staple firing motion.

7. The staple cartridge of claim 5 , wherein said outer layer is comprised of a compressible polymer, and wherein said compressible polymer is water impermeable.

8. The staple cartridge of claim 1 , wherein said adjunct further comprises a medicament in a reservoir volume, and wherein said medicament comprises at least one of a liquid, a gel, or a dry powder.

9. The staple cartridge of claim 8 , wherein said inner layer defines said reservoir for said medicament.

10. The staple cartridge of claim 9 , wherein said inner layer encloses said reservoir.

11. The staple cartridge of claim 9 , wherein said reservoir is defined by an inner surface of said outer layer and an outer surface of said inner layer such that said inner layer is surrounded by said reservoir.

12. A staple cartridge, comprising:

a cartridge deck;

a longitudinal slot extending through said cartridge deck from a proximal end to a distal end;

staple cavities defined in said cartridge deck;

staples removably stored in said staple cavities; and

an adjunct positioned on said cartridge deck, said adjunct comprising:

an outer shell; and

an inner core, wherein said inner core comprises a biocompatible material enclosed by said outer shell, and wherein said adjunct is configured to be compressed during a firing motion.

13. The staple cartridge of claim 12 , wherein said outer shell comprises an absorbable polymer.

14. The staple cartridge of claim 12 , wherein said inner core comprises fibers.

15. The staple cartridge of claim 12 , wherein said inner core comprises a powder medicament.

16. The staple cartridge of claim 12 , wherein said inner core comprises a reservoir volume containing said biocompatible material.

17. The staple cartridge of claim 16 , wherein said biocompatible material comprises at least one of a liquid, a gel, or a dry powder.

18. The staple cartridge of claim 12 , wherein said outer shell comprises a tubular geometry.

19. The staple cartridge of claim 18 , wherein said adjunct further comprises one or more additional outer shells comprising said tubular geometry, each of said additional outer shells enclosing a respective inner core comprising a biocompatible material.

20. The staple cartridge of claim 19 , wherein said outer shells are arranged in a row on said cartridge deck.

Assignments (4)
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY DATA NOTICE OF RECORDATION ASSIGNEE TO CILAG GMBH INTERNATIONAL PREVIOUSLY RECORDED ON REEL 059211 FRAME 0442. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Apr 20, 2022
From: SWAYZE, JEFFREY S.
To: CILAG GMBH INTERNATIONAL
Reel/Frame 059744/0908 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 9, 2022
From: SHELTON, FREDERICK E., IV
To: ETHICON LLC
Reel/Frame 059211/0241 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 9, 2022
From: SWAYZE, JEFFREY S.
To: INTERNATIONAL, CILAG GMBH
Reel/Frame 059211/0442 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2021
From: ETHICON LLC
To: CILAG GMBH INTERNATIONAL
Reel/Frame 056601/0339 →
Continuity (7)
Continuation 16851528 · Apr 17, 2020
Continuation 15480854 · Apr 6, 2017
Continuation 14220779 · Mar 20, 2014
Continuation In Part 13433175 · Mar 28, 2012
Continuation In Part 13097891 · Apr 29, 2011
Continuation In Part 12894377 · Sep 30, 2010
Related Publication 20210259987A1 · Aug 26, 2021
Cited By (3)
US 12,213,671 US 12,408,914 US 12,446,877